Healthcare Services & Equipment

TradingKey - Medtronic (MDT) reported its first-quarter fiscal 2027 financial results, with both revenue and earnings exceeding market expectations, while raising its full-year growth outlook. Boosted by the strong earnings report, Medtronic shares rose nearly 9% in pre-market trading.

TradingKey - In August 2026, the upward momentum in US stocks broadened significantly. Moderna (MRNA) topped the S&P 500 constituents with a 156% gain, surging 375.9% year-to-date. Palantir (PLTR) followed closely behind, rising 51.5% in August, while enterprise software stocks as a whole extended their previous recovery.

TradingKey - Billionaire investor Bill Ackman's Pershing Square revealed in its latest disclosure that the firm initiated a new position in Netflix (NFLX) in the second quarter, while also buying Visa (V), Mastercard (MA), S&P Global (SPGI), Intercontinental Exchange (ICE), and Alcon (ALC), adding a total of six companies.

TradingKey - On July 28 ET, Berkshire Hathaway Class B shares (BRK.B) closed at $512.37, marking the highest closing price since November 28 of last year ($513.81), but remaining approximately 5% below the all-time closing high of $539.80 reached on May 2, 2025. Class A shares (BRK.A) also trended higher, closing at $768,010 on Tuesday, with an all-time high of $809,350 recorded on the same day.

TradingKey - NovoCure surged to $19.91 after Q2 2026 earnings released this morning. Revenue consensus was $172M growing 8.6% YoY. The story is Optune Pax's FDA approval and multi-indication expansion after June's TRIDENT trial disappointment. Here is the setup.

TradingKey - UnitedHealth beat Q2 2026 EPS by 30%, reported an 86.7% medical cost ratio (down from 89.4%), and raised full-year guidance to $19.50 to $20.00 per share. At $425 in a rising channel, here’s what $454 needs and why the DOJ investigation still matters.